These analyses suggest that SIRPG SNP genotypes may associate with high-risk HLA diplotypes, thus reinforcing the importance of examining the roles of both HLA and non-HLA risk SNPs in modulating events driving tissue-specific reactivity in the pathogenesis of T1D (93). This evidence concerns the gene SIRPG and type 1 diabetes mellitus.